460 related articles for article (PubMed ID: 11755929)
1. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells.
Doi M; Shichiri M; Katsuyama K; Ishimaru S; Hirata Y
Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells.
Doi M; Shichiri M; Katsuyama K; Marumo F; Hirata Y
Hypertens Res; 2000 Nov; 23(6):659-67. PubMed ID: 11131279
[TBL] [Abstract][Full Text] [Related]
3. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Kato H; Imai T; Marumo F; Hirata Y
Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970
[TBL] [Abstract][Full Text] [Related]
5. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Hirata Y
J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
[TBL] [Abstract][Full Text] [Related]
6. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways.
Kleinert H; Wallerath T; Fritz G; Ihrig-Biedert I; Rodriguez-Pascual F; Geller DA; Förstermann U
Br J Pharmacol; 1998 Sep; 125(1):193-201. PubMed ID: 9776360
[TBL] [Abstract][Full Text] [Related]
7. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1796-802. PubMed ID: 9812920
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB.
Marcus JS; Karackattu SL; Fleegal MA; Sumners C
Glia; 2003 Jan; 41(2):152-60. PubMed ID: 12509805
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation.
Hattori Y; Hattori S; Kasai K
Eur J Pharmacol; 2003 Nov; 481(2-3):153-8. PubMed ID: 14642780
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells.
Pahan K; Raymond JR; Singh I
J Biol Chem; 1999 Mar; 274(11):7528-36. PubMed ID: 10066820
[TBL] [Abstract][Full Text] [Related]
11. Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle.
Kessler P; Kronemann N; Hecker M; Busse R; Schini-Kerth VB
J Cardiovasc Pharmacol; 1997 Dec; 30(6):802-10. PubMed ID: 9436821
[TBL] [Abstract][Full Text] [Related]
12. LPS induction of I kappa B-alpha degradation and iNOS expression in a skin dendritic cell line is prevented by the janus kinase 2 inhibitor, Tyrphostin b42.
Cruz MT; Duarte CB; Gonçalo M; Carvalho AP; Lopes MC
Nitric Oxide; 2001 Feb; 5(1):53-61. PubMed ID: 11178937
[TBL] [Abstract][Full Text] [Related]
13. beta-very low density lipoprotein enhances inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells.
Takahashi M; Takahashi S; Shimpo M; Naito A; Ogata Y; Kobayashi E; Ikeda U; Shimada K
Atherosclerosis; 2002 Jun; 162(2):307-13. PubMed ID: 11996950
[TBL] [Abstract][Full Text] [Related]
14. Growth factors enhance interleukin-1 beta-induced persistent activation of nuclear factor-kappa B in rat vascular smooth muscle cells.
Jiang B; Xu S; Brecher P; Cohen RA
Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1811-6. PubMed ID: 12426209
[TBL] [Abstract][Full Text] [Related]
15. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
[TBL] [Abstract][Full Text] [Related]
16. Role of mitogen-activated protein kinases and tyrosine kinases on IL-1-Induced NF-kappaB activation and iNOS expression in bovine articular chondrocytes.
Mendes AF; Caramona MM; Carvalho AP; Lopes MC
Nitric Oxide; 2002 Feb; 6(1):35-44. PubMed ID: 11829533
[TBL] [Abstract][Full Text] [Related]
17. Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells.
Hattori Y; Nakanishi N; Kasai K
Cardiovasc Res; 2002 Jun; 54(3):649-58. PubMed ID: 12031711
[TBL] [Abstract][Full Text] [Related]
18. Non-NF-kappaB elements are required for full induction of the rat type II nitric oxide synthase in vascular smooth muscle cells.
Zhang H; Teng X; Snead C; Catravas JD
Br J Pharmacol; 2000 May; 130(2):270-8. PubMed ID: 10807663
[TBL] [Abstract][Full Text] [Related]
19. 4-hydroxynonenal prevents NO production in vascular smooth muscle cells by inhibiting nuclear factor-kappaB-dependent transcriptional activation of inducible NO synthase.
Hattori Y; Hattori S; Kasai K
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1179-83. PubMed ID: 11451748
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of nitric oxide synthase mRNA expression by lipopolysaccharide and pro-inflammatory cytokines in fetal hepatocytes treated with cycloheximide.
Casado M; Díaz-Guerra MJ; Boscá L; Martín-Sanz P
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):819-23. PubMed ID: 9581561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
